IP Library › Patent Application 17201116
Patent Application
App. No. 17/201,116

SYSTEMS AND METHODS FOR SEALING CORED OR PUNCTURED TISSUE USING FILL MATERIAL

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/201,116
Abstract

Systems and methods for sealing tissue sites may comprise coring tissue at a target site such that a tissue core is removed from the target site thereby creating a core cavity at the target site and causing sealing of at least a portion of the target site.

Claims (42)

1 . A method for sealing tissue, the method comprising:

disposing a port to provide access to a target site;

anchoring an anchor device, via the port, to a surface at the target site;

disposing, via the port, a sealing device adjacent the target site;

causing the sealing device to seal the target site; and

disposing a fill material adjacent the target site, wherein the sealing device minimizes escape of the fill material from the target site.

2 . The method of claim 1 , wherein the target site comprises biological tissue.

3 . The method of claim 1 , wherein the target site comprises tissue of a lung, and wherein the fill material promotes pneumostasis.

4 . The method of claim 1 , wherein the target site comprises a cored tissue or a punctured tissue.

5 . The method of claim 1 , wherein the sealing device comprises one or more of an inflatable balloon or an inflatable balloon catheter.

6 . The method of claim 1 , wherein causing the sealing device to seal the target site comprises causing at least a portion of the sealing device to abut a portion of the target site.

7 . The method of claim 1 , wherein the target site comprises at least a portion of a lung and further comprising causing the lung to collapse prior to disposing the sealing device adjacent the target site.

8 . The method of claim 1 , wherein the target site comprises at least a portion of a lung and further comprising allowing the lung to ventilate while the sealing device is sealing the target site.

9 . The method of claim 1 , wherein the fill material comprises autologous blood.

10 . The method of claim 1 , wherein the fill material comprises blood or a blood substitute, and a clotting agent.

11 . The method of claim 1 , further comprising spacing the sealing device from the target site after the fill material is disposed.

12 . The method of claim 1 , further comprising disposing a closure material or closure device adjacent the target site to at least partially enclose a cavity at the target site.

13 . The method of claim 12 , further comprising spacing the closure device from the target site.

14 . The method of claim 12 , further comprising leaving the closure device at the target site.

15 . The method of claim 12 , wherein the closure device is implantable or absorbable.

16 . A method for sealing tissue, the method comprising:

disposing a fluid delivery device adjacent a target site comprising biological tissue;

disposing a fill material into the target site to effect sealing of at least a portion of the target site; and

spacing a fluid delivery device from the target site.

17 . The method of claim 16 , wherein the target site comprises tissue of a lung, and wherein the fill material promotes pneumostasis.

18 . The method of claim 16 , wherein the target site comprises a cored tissue or a punctured tissue.

19 . The method of claim 16 , wherein the target site comprises at least a portion of a lung and further comprising causing the lung to collapse prior to disposing the fluid delivery device adjacent the target site.

20 . The method of claim 16 , wherein the target site comprises at least a portion of a lung and further comprising allowing the lung to ventilate while the fill material is sealing the target site.

21 . The method of claim 16 , wherein the fill material comprises autologous blood.

22 . The method of claim 16 , wherein the fill material comprises blood or a blood substitute, and a clotting agent.

23 . The method of claim 16 , further comprising disposing a closure material or closure device adjacent the target site to at least partially enclose a cavity at the target site.

24 . The method of claim 23 , further comprising spacing the closure device from the target site.

25 . The method of claim 23 , further comprising leaving the closure device at the target site.

26 . The method of claim 23 , wherein the closure device is implantable or absorbable.

27 . A method for sealing tissue, the method comprising:

coring tissue at a target site such that a tissue core is removed from the target site thereby creating a core cavity at the target site; and

disposing a fill material in the core cavity, wherein the fill material minimize ingress of fluid into the core cavity.

28 . The method of claim 27 , wherein the target site comprises tissue of a lung, and wherein the fill material promotes pneumostasis.

29 . The method of claim 27 , wherein the target site comprises at least a portion of a lung and further comprising causing the lung to collapse prior to fill material in the core cavity.

30 . The method of claim 27 , wherein the target site comprises at least a portion of a lung and further comprising allowing the lung to ventilate while the fill material is sealing the target site.

31 . The method of claim 27 , wherein the fill material comprises autologous blood.

32 . The method of claim 27 , wherein the fill material comprises blood or a blood substitute, and a clotting agent.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 29, 2026
From: COHN, WILLIAM; DAGLOW, TERRY; KUHN, MATTHEW; MILLS, CHRIS; NGUYEN, STEVEN; ROSENGARD, BRUCE; SHARMA, TUSHAR; FISCHEL, RICHARD
To: ETHICON, INC.
Reel/Frame 074533/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2022
From: ETHICON, INC.
To: PRANA THORACIC, INC.
Reel/Frame 061820/0056 →